C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2006
11/15/2006	EP1720900A1 Fusion proteins comprising modified allergens of the ns-ltps family, use thereof and pharmaceutical compositions comprising the same
11/15/2006	EP1720899A2 Multimerised hiv fusion inhibitors
11/15/2006	EP1720898A2 Antihypertensive peptides from casein hydrolysates
11/15/2006	EP1720888A2 Antimicrobial carbohydrates and methods of using same
11/15/2006	EP1720530A2 Screening method for emulators of neural activity and digestive system using gpr35
11/15/2006	EP1720415A1 Preparation of canola protein isolate and use in aquaculture
11/15/2006	EP1720410A1 Compositions and methods for the treatment and clinical remission of psoriasis
11/15/2006	EP1687328A4 Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction
11/15/2006	EP1615996A4 Uses of vascular endothelial growth factor and type i collagen inducible protein (vcip)
11/15/2006	EP1560915A4 Assay methods for state-dependent calcium channel agonists/antagonists
11/15/2006	EP1539996A4 Method of producing plants having enhanced transpiration efficiency and plants produced therefrom
11/15/2006	EP1516188B1 Method for identifying and extracting endotoxin
11/15/2006	EP1412383B1 Peptide conjugates, their derivatives with metal complexes and use thereof for magnetic resonance imaging (mri)
11/15/2006	EP1407014B1 Screening method for attenuating or virulence defective microbial cells
11/15/2006	EP1283869B1 Novel bee venom polypeptides and methods of use thereof
11/15/2006	EP1278768B1 Method for identifying helicobacter antigens
11/15/2006	EP1222281B1 Immunoligically significant herpes simplex virus antigens
11/15/2006	EP1208214B1 Genetically engineered bleb vaccine
11/15/2006	EP1064372B1 Compounds and methods for therapy and diagnosis of lung cancer
11/15/2006	EP1054950B1 Hiv chemokines
11/15/2006	EP1051502B1 Highly efficient controlled expression of exogenous genes in e. coli
11/15/2006	EP1039921B1 Substantially pure histidine-linked protein polymer conjugates
11/15/2006	EP1008351B1 Carcinostatic agents
11/15/2006	EP0758381B2 Biologically active eph family ligands
11/15/2006	CN1864068A Methods for reducing complexity of a sample using small epitope antibodies
11/15/2006	CN1863920A Conjugation of peptides
11/15/2006	CN1863918A Packaging cells for recombinant adenovirus
11/15/2006	CN1863912A A fungal immuromodulatory protein produced by microorganisme and uses there of
11/15/2006	CN1863911A Method for controlled induction of somatic mutations and use thereof in proteomics
11/15/2006	CN1863820A Compounds comprising lpa
11/15/2006	CN1863818A Anti-VEGF antibodies
11/15/2006	CN1863816A Process for preparation of flax protein isolate
11/15/2006	CN1863550A Use of secretagogues like ghrelin in cancer cachexia and for stimulating appetite
11/15/2006	CN1863549A Conjugates of a polymer and a protein linked by an oxime linking group
11/15/2006	CN1863548A Methods and compositions for treating disorders of the extracellular matrix
11/15/2006	CN1863547A P185-encoding DNA and therapeutical uses thereof
11/15/2006	CN1863546A Methods for treating cardiovascular disease using a soluble ctla4 molecule
11/15/2006	CN1861790A Preparation process of human recombined parathyroid hormone 1 84
11/15/2006	CN1861657A Poly ethyldiol modified methyl propenoic acid glycidyl ester resin, preparation process and application thereof
11/15/2006	CN1861635A Human pancreas hyperglycemiacin relative peptide-2 analogue
11/15/2006	CN1861634A Dog interferon alpha, preparation process and use thereof
11/15/2006	CN1861633A Toxophasma gondii detecting kit based on recombined antigen
11/15/2006	CN1861632A Coupling compound of Norfloxacin, preparation process and application thereof
11/15/2006	CN1861631A Coupling compound of tetracycline, preparation process and application thereof
11/15/2006	CN1861630A Active segment of HER2/neu with Herstatin interaction, coding gene and application thereof
11/15/2006	CN1861628A Process for separating protein of Chinese medicine
11/15/2006	CN1861036A Preserving a hemoglobin blood substitute with a transparent overwrap
11/15/2006	CN1284859C Membrane virus host range mutations and their uses as vaccine substrates
11/15/2006	CN1284853C Gene encoding protease inhibitor and encoded protein thereby
11/15/2006	CN1284798C Poly thymosin-alpha 1, its composition, its preparation method and application
11/15/2006	CN1284797C Method for constructing, expressing and purifying human recombination factor and application
11/14/2006	US7135629 Inbred corn line 4XP811
11/14/2006	US7135625 Comprises exxpression vector nucleotide sequences coding plant growth regulators for producing transgenic rice plants; generating disease resistant plants
11/14/2006	US7135622 Mevalonate synthesis enzymes
11/14/2006	US7135621 Control of fruit dehiscence in plants by Indehiscent1 genes
11/14/2006	US7135618 Vectors coding for lipid metabolism protein for improving seed storage; acyltransferaseses
11/14/2006	US7135616 Biochemistry-related polynucleotides and polypeptides in plants
11/14/2006	US7135613 Zebrafish emit green fluorescence under blue or ultraviolet light according to specificity of promoters in germ or somatic cells; capable of breeding to produce viable and fertile progeny
11/14/2006	US7135612 Identification of the gene causing the mouse scurfy phenotype and its human ortholog
11/14/2006	US7135611 Animal models for use in identifying modulators for treatment of obesity
11/14/2006	US7135610 Mouse showing neurofibril change due to senile dementia
11/14/2006	US7135605 Metal binding proteins and associated methods
11/14/2006	US7135559 Proteins and novel genes encoding the same
11/14/2006	US7135556 NPC1L1 (NPC3) and methods of use thereof
11/14/2006	US7135554 Exposing the stabilized hemoglobin solution to glutaraldehyde to further polymerize at least a portion of the hemoglobin present in the stabilized hemoglobin solution, whereby the average molecular weight of stabilized hemoglobin solution increases to thereby produce the polymerized hemoglobin solution
11/14/2006	US7135553 Polymerizing hemoglobin with glutaraldehyde in solution, treating the polymerized hemoglobin to elaborate tetramer and removing tetramer from the polymerized hemoglobin solution
11/14/2006	US7135552 Useful as a candidate for a vaccine against ticks, particularly Ornithodoros moubata
11/14/2006	US7135551 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of glandular disorders
11/14/2006	US7135549 Can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 184P1E2 can be used in active or passive immunization
11/14/2006	US7135463 inhibiting the growth of a cancerous cell by contacting cell with an effective amount of a RhoB protein, or a variant of the RhoB protein; alone or in combination with additional anti-cancer agents, such as cytotoxic agents (e.g., 5-flurouracil)
11/14/2006	US7135459 Using fibroblast growth factor (zFGF5) compositions to proliferate chondrocytes and their progenitors and to induce deposits of cartilage; injuries; defects; neurological disorders such as stroke; bone disorcers; antiischemic agents
11/14/2006	US7135458 Interferon-γ inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use
11/14/2006	US7135456 Glial mitogenic factors, their preparation and use
11/14/2006	US7135454 Use of SLURP-1 compositions for treating schizophrenia
11/14/2006	US7135453 Reagents and methods for smooth muscle therapies
11/14/2006	US7135452 Recombinant SP-A for the treatment or prevention of pulmonary infection and inflammation
11/14/2006	US7135339 Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV)
11/14/2006	US7135338 Methods for overexpression of high molecular weight form of mannose binding lectin (MBL) and a specific formulation for active treatment for systemic infection with microorganism
11/14/2006	US7135337 Nucleotide sequences for use in biological pest control
11/14/2006	US7135334 Stimulating or inhibiting angiogenesis and/or cardiovascularization in mammals, including humans. Pharmaceutical compositions are based on polypeptides or antagonists thereto that have been identified for one or more
11/14/2006	US7135333 A CRCA-1 transcript nucleic acid and polynucleotide; host cells; anticarcinogenic agents, gene therapy, antisense agents, vaccines
11/14/2006	US7135320 Adaptor protein FRS2 and related products and methods
11/14/2006	US7135310 Method to amplify variable sequences without imposing primer sequences
11/14/2006	US7135307 Gamma three protease
11/14/2006	US7135303 Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding
11/14/2006	US7135280 Assay to determine efficacy of treatment for mycobacterial infection
11/14/2006	US7135279 4-alpha glucotransferases; enzymes inhibitors; enantimorphs; adrenergic blocking agents; proteases; superoxide dismutases; carbonic anhydrases
11/14/2006	US7135188 Methods and compositions for immunotherapy of cancer
11/14/2006	US7135186 Varicella zoster virus (VZV) immunoreactive protein VP26 and its diagnostic use
11/14/2006	US7135185 Conserved motif of hepatitis C virus E2/NS1 region
11/14/2006	US7135182 Administration of substrates for transglutaminases or antibodies against such substrates; identification, prevention or treatment of microbial infection of mammalian hosts such as immunocompromised or immunosuppressed humans
11/14/2006	US7135181 Method for down-regulation of amyloid
11/14/2006	US7135179 Methods for treating sarcoidosis using anti-TNF antibodies and fragments thereof
11/14/2006	US7135178 Methods of treating disseminated intravascular coagulation using anti-TNF antibodies
11/14/2006	US7135176 VMP-like sequences of pathogenic Borrelia
11/14/2006	US7135175 Compositions and methods for eliciting an immune response to gram-negative bacterial infections
11/14/2006	US7135171 Endothelial precursor cells for enhancing and restoring vascular function
11/14/2006	US7135170 Methods for treating viral infection using IL-28 and IL-29
11/14/2006	CA2343099C Role of human kis (hkis) as an inhibitory kinase of the cyclin-dependentkinase inhibitor p27. compositions, methods and uses thereof to control cell proliferation
11/14/2006	CA2139571C Interferon receptor binding peptides

1 ... 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 ... 2916